Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|April 4, 2019
Vascular stiffness: influencing factors on carotid-femoral pulse wave velocity in systemic lupus erythematosusMarco Stortz, Konstantinos Triantafyllias, Andreas Schwarting, et al.
Journal of Clinical Medicine|May 14, 2025
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven CasesAndreas Kommer, Marco Stortz, Daniel Kraus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2026
Bleeding risk after kidney biopsy with platelet inhibitionDaniel Kraus, Razan Sadek, Andreas Kommer, et al.
Clinical Case Reports|November 13, 2023
Plasma exchange for treatment of a therapy-related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma-A case reportMarco Stortz, Kateryna Shmanko, Daniel Kraus, et al.
Trials|April 2, 2025
Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndromeMarco Stortz, Pascal Klimpke, Andreas Kommer, et al.
Clinical and Experimental Rheumatology|April 4, 2019
High cardiovascular risk in mixed connective tissue disease: evaluation of macrovascular involvement and its predictors by aortic pulse wave velocityKonstantinos Triantafyllias, Michele de Blasi, Freya Lütgendorf, et al.
Clinical and Experimental Rheumatology|September 26, 2025
Anifrolumab in systemic lupus erythematosus: real-world experience from a single academic tertiary care centrePaul Classen, Simone Boedecker-Lips, Vanessa Tomalla, et al.
The Lancet Regional Health. Europe|June 19, 2026
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover TrialMarco Stortz, Andreas Kommer, Myriam Meineck, et al.
Clinical Kidney Journal|March 27, 2026
Increased albuminuria is highly prevalent in the general population: prevalence of CKD in the Gutenberg Health StudyDaniel Kraus, Alexander Gieswinkel, Simone Cosima Boedecker-Lips, et al.
Pageof 1